Jan 20, 20233 minBioMed X and AbbVie Extend Research Collaboration in the USBioMed X establishes its first US-based institute in New Haven with a new immunology research project in collaboration with AbbVie....
Jan 13, 20233 minBayer to Accelerate Drug Discovery with Google Cloud’s High-Performance Compute PowerBayer to speed up its in-silico research and development with Google Cloud’s high-speed processors / Collaboration aims to enable Bayer...
Jan 13, 20235 minBausch + Lomb and Novaliq Announce Publication of Pivotal Phase 3 Data on NOV03Bausch + Lomb and Novaliq Announce Publication of Pivotal Phase 3 Data on NOV03 (Perfluorohexyloctane) in Ophthalmology NOV03 is Being...
Dec 16, 20223 minProtecting the next generations with vaccines‘Protecting the next generations: fighting diseases of poverty and preventing emerging infections” is the title of the new European...
Dec 2, 20221 minHeidelberg / Mannheim University Hospital Link-Up: Reviewed and Rapid Implementation RecommendedJoint press release by the City of Mannheim, Heidelberg University Hospital, Mannheim University Hospital and Heidelberg University “In...
Dec 2, 20223 minGenomic Data Infrastructure – integrating genomics into healthcareNew European Commission project will provide cross-borders access to at least one million genomes and related clinical data The European...
Nov 21, 20222 minOpen Targets consortium welcomes Genentech as newest memberOpen Targets announced today that Genentech, a member of the Roche Group, has joined the consortium, which identifies, prioritises, and...
Nov 14, 20223 minHeidelberg Pharma’s Partner Telix Reports Positive Data on the Pivotal ZIRCON StudyLadenburg, Germany, 7 November 2022 – Heidelberg Pharma AG (FSE: HPHA) announced today that its licensing partner Telix Pharmaceuticals...
Nov 7, 20227 minAffimed and Artiva Biotherapeutics Announce Partnership Affimed and Artiva Biotherapeutics Announce Partnership to Advance Combination Therapy of Innate Cell Engager (ICE®) AFM13 and...